Technical Analysis for GBS - GBS Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical GBS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Spinning Top | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -0.89% | |
| Wide Bands | Range Expansion | -0.89% | |
| Oversold Stochastic | Weakness | -0.89% | |
| Narrow Range Bar | Range Contraction | 2.46% | |
| NR7 | Range Contraction | 2.46% | |
| Stochastic Reached Oversold | Weakness | 2.46% | |
| Wide Bands | Range Expansion | 2.46% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 7 hours ago |
| Up 3% | about 7 hours ago |
| Up 2% | about 7 hours ago |
| Rose Above Previous Day's High | about 8 hours ago |
| Down 3% | about 8 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diabetes Tumor Glucose Diagnostic Tests Biomarkers Blood Glucose Monitoring Monitoring Diabetes Management Chemical Pathology Biosensor
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diabetes Tumor Glucose Diagnostic Tests Biomarkers Blood Glucose Monitoring Monitoring Diabetes Management Chemical Pathology Biosensor
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.2399 |
| 52 Week Low | 2.441 |
| Average Volume | 962,294 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 3.55 |
| 20-Day Moving Average | 3.53 |
| 10-Day Moving Average | 3.47 |
| Average True Range | 0.43 |
| ADX | 23.64 |
| +DI | 28.36 |
| -DI | 19.14 |
| Chandelier Exit (Long, 3 ATRs) | 3.83 |
| Chandelier Exit (Short, 3 ATRs) | 4.18 |
| Upper Bollinger Bands | 4.10 |
| Lower Bollinger Band | 2.96 |
| Percent B (%b) | 0.32 |
| BandWidth | 32.35 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0332 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.69 | ||||
| Resistance 3 (R3) | 3.70 | 3.60 | 3.63 | ||
| Resistance 2 (R2) | 3.60 | 3.50 | 3.59 | 3.61 | |
| Resistance 1 (R1) | 3.46 | 3.45 | 3.41 | 3.45 | 3.59 |
| Pivot Point | 3.36 | 3.36 | 3.33 | 3.35 | 3.36 |
| Support 1 (S1) | 3.22 | 3.26 | 3.17 | 3.21 | 3.07 |
| Support 2 (S2) | 3.12 | 3.21 | 3.11 | 3.05 | |
| Support 3 (S3) | 2.98 | 3.12 | 3.03 | ||
| Support 4 (S4) | 2.97 |
